Drug intelligence / Profile preview

tetrofosmin

Development stage
Approved
Lead developer
GE Healthcare
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

Tetrofosmin is a small molecule diphosphine ligand used in conjunction with the radioisotope technetium-99m to form the radiopharmaceutical technetium Tc 99m tetrofosmin. This compound is primarily used for myocardial perfusion imaging (MPI) in nuclear medicine to assess blood flow to the heart muscle under both stress and rest conditions. The mechanism of action involves passive diffusion of the lipophilic cationic complex into viable myocardial cells, where it accumulates in proportion to regional blood flow and binds mainly within mitochondria. Areas with reduced uptake indicate compromised perfusion due to coronary artery disease or infarction. Tetrofosmin was developed as an improved agent for cardiac imaging due to its favorable biodistribution and rapid clearance from non-target tissues[2][5][6][7].

Brand names
Myoview
Other names
technetium tc 99m tetrofosmintechnetium-99m tetrofosmintechnetium99m tetrofosmintechnetium 99m tetrofosminTc-99m tetrofosminTc99m tetrofosminTc 99m tetrofosmin

Beyond the preview

Go deeper on tetrofosmin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tetrofosmin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call